HNWAG
GDRX icon

High Net Worth Advisory Group’s GoodRx Holdings GDRX Stock Holding History

High Net Worth Advisory Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$46.6K – 339
2022
Q4 		$46.6K Buy
+10,000
New +$49.3K 0.02% 339

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

High Net Worth Advisory Group's GDRX Position: Q1 2023 in Review

High Net Worth Advisory Group sold out of GoodRx Holdings (GDRX) in Q1 2023, closing a stake of 10,000 shares — an estimated $46.6K sold.

High Net Worth Advisory Group first reported a position in GDRX in Q4 2022 and held it in 1 quarter. The position peaked at $46.6K in Q4 2022. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2023.

  • High Net Worth Advisory Group reported no remaining GoodRx Holdings position as of Q1 2023 after selling out during the quarter.
  • High Net Worth Advisory Group sold 10,000 GoodRx Holdings shares in Q1 2023, an estimated $46.6K.
  • High Net Worth Advisory Group first reported a position in GoodRx Holdings in Q4 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's GoodRx Holdings position peaked at $46.6K in Q4 2022.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2023.

Based on High Net Worth Advisory Group's 13F filing for Q1 2023, filed 20 Apr 2023.